SHANGHAI and GAITHERSBURG, Md., June 29, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and ...

GAITHERSBURG, MD. and SHANGHAI, China, Oct. 5, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and ...

I-Mab, a late-stage cancer/autoimmune biotech developing in-licensed antibodies in China, raised $104 million by offering 7.4 million ADSs at $14, within the range of $12 to $15. I-Mab plans to ...

U.S. drugmaker AbbVie Inc will pay $180 million in upfront payment to develop and sell Chinese biotech company I-Mab's cancer drug, the companies said on Friday.

The Ministry of Environment of Peru (MINAM) through its National Service of Natural Areas Protected by the State (SERNANP) and UNESCO’s Man and Biosphere (MAB) Programme jointly announce the 4th World ...

Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights Provided by GlobeNewswire Mar 20, 2025, 12:01:00 PM ...